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Abstract
Although genetics is the most significant known determinant of human intelligence, specific gene contributions remain
largely unknown. To accelerate understanding in this area, we have taken a new approach by studying the relationship
between quantitative gene expression and intelligence in a cohort of 65 patients with Williams Syndrome (WS), a
neurodevelopmental disorder caused by a 1.5 Mb deletion on chromosome 7q11.23. We find that variation in the transcript
levels of the brain gene STX1A correlates significantly with intelligence in WS patients measured by principal component
analysis (PCA) of standardized WAIS-R subtests, r =0.40 (Pearson correlation, Bonferroni corrected p-value =0.007),
accounting for 15.6% of the cognitive variation. These results suggest that syntaxin 1A, a neuronal regulator of presynaptic
vesicle release, may play a role in WS and be a component of the cellular pathway determining human intelligence.
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Introduction
Intelligence is a largely heritable, quantitative trait that varies
from mild mental retardation to highly gifted [1]. Despite decades
of intensive research, there are few proven links between genes and
cognitive function, none explaining more than a few percent of
cognitive variation [2,3,4]. Human intelligence is measured by a
series of tests that have been standardized in the normal
population using the Intelligence Quotient (IQ), as defined by
the Wechsler Adult Intelligence Scale-Revised (WAIS-R), which is
determined by 11 subtests grouped into two categories, one verbal
IQ (VIQ) and the other visual-spatial or performance IQ (PIQ)
[5].
Neurodevelopmental disorders such as Williams Syndrome
(WS) offer a unique opportunity to probe the connections between
genes and IQ in that WS is caused by deletion of about 28 genes
located in a 1.5 Mb region on chromosome 7q11.23. Williams
Syndrome presents with a distinct pattern of intellectual disabilities
that differ from normal on subtests of the WAIS-R. In general, WS
cases exhibit relative peaks in verbal ability and valleys in visual-
spatial processing [6,7,8]. Specifically, relative to their overall
performance, WS subjects tend to do well in tests of vocabulary
(Vocabulary) and abstract reasoning (Similarities, Picture Ar-
rangement), and poorly in tests of numeracy (Arithmetic), visual-
spatial (Digit Symbol, Block Design, Object Assembly), and
memory (Digit Span) [6]. Therefore, the IQ determined by the
WAIS-R, standardized in the normal population, may not
optimally reflect variations in cognitive function in those with
WS, limiting the ability to discern correlations with genetic
variation. The breakpoints that are clustered in the regions of
highly repetitive DNA segments that flank the WS deletion further
constrain the power to resolve genetic contributions to WS
cognition. These breakpoints result in hemizygosity for the same
set of genes in the majority of WS cases (Fig. 1). Therefore, a major
question in the field has been the genetic causes of the cognitive
variation found in typical WS.
To begin to correlate cognitive deficits with specific deleted
genes, we and others have studied rare WS individuals with
smaller deletions [7,8,9,10,11]. This leads to the suggestion of a
role for GTF2I and GTF2IRD1 in the visual-spatial construction
and associated neuroanatomical defects of posterior cortices seen
in WS patients [7,11]. However, the number of atypical deletions
is small and has limited such analyses. Another potential source of
genetic variation in WS is the level of activity of the genes
remaining on the non-deleted chromosome 7. That is, with a
deletion of chromosome 7q11.23, persons with WS lose one copy
and remain with only a single copy of the genes in this region. It is
the decreased or altered ability of this single remaining gene copy
to generate normal transcription that is ultimately responsible for
the features of WS. Although variation in locus specific gene
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neglected as a source of variation in WS. The current report
addresses the problem of genetic variation in WS by using
quantitative gene expression and principal components analysis
(PCA) to investigate how genetic variation is related to cognition in
the vast majority of WS subjects with typical deletions.
Our basic hypothesis is that the severity of cognitive deficits is
related to the expression levels of the WS region genes that remain
on the normal chromosome 7 that is inherited. Since measuring
gene expression in the tissue of interest (brain) is not possible, we
and others [13,14] have quantitated gene expression in lympho-
blastoid (LB) cell lines. Clearly there are tissue specific patterns of
gene expression that differentiate brain (or other tissues affecting
intelligence) and lymphoid tissues. Thus, expression in lympho-
blastoid cells may not be well correlated with gene expression
levels in cells that directly impact intelligence. Further, the cellular
processes of lymphoblastoid cells may be more or less related to
brain tissue functions than are typical, non-transformed lympho-
cytes. Nonetheless, the use of lymphoblastoid cells is supported by
previous work showing lymphoblast and lymphocyte gene
expression to be altered in fragile X and dup15q autism subtypes
[15], as well as in other neuropsychiatric diseases such as
schizophrenia, depression, stress and anxiety, and Alzheimer
disease [16,17,18]. Interestingly, lymphocytes have voltage-gated
calcium channel subunits typically limited to excitable cells
[19,20], and respond to neurotransmitters such as GABA GAT-
1 [21,22], dopamine [23], serotonin [24], vasopressin [25], and
epinephrine/norepinephrine [26]. We therefore considered the
possibility that a subset of WS genes might act in cellular processes
that affect the development and function of both the brain and the
immune system.
WS cognition is distinctive, and one challenge has been to
reflect the distinctive peaks and valleys of WS brain and cognitive
patterns using IQ subtests standardized on normal individuals
(Fig. 2). To address this, we used principal component analysis
(PCA) to identify the unique subtest patterns of the WAIS-R found
in WS. PCA analysis looks at the correlations of all subtests and
seeks to capture most of the observed variation across the tests by a
small number of linear combinations of the subtests. The first and
most important principal component (PC1) of WAIS-R subtests
determined in the normal population is mostly weighted (or
loaded) on verbal ability. Because this verbal predominance may
be false for WS patients, IQ calculated in the usual way may not
optimally reflect the variation in WS cognitive function.
Therefore, PCA may more accurately model the distinct cognitive
profile of WS than do standard IQ summary measures. Since PCA
can generate a single measure of intellectual performance, it
sidesteps many of the multiple testing issues that arise in dealing
with the full multiplicity of subtests.
In the current study of a large cohort with WS (n=65), we
correlate cognitive performance as reflected in PCA with
quantitative expression levels of 10 genes located in the WS
deletion, determined by quantitative RT-PCR. We find that the
relative expression of the STX1A gene accounts for 15.6% of the
variance in the first principal component of the WAIS-R in WS
cases. After correcting for multiple tests, the evidence clearly
indicates that expression levels of STX1A partially predict
intelligence in WS. Whether STX1A exerts a similar influence in
normal controls and whether the effect is due to genetic variation
of STX1A (cis effects) or to regulators in the remainder of the
genome (trans effects) is unknown. However, our results suggest
that monitoring gene expression may provide unique insights into
the neurobiology and genetics of intelligence in WS subjects and
possibly the normal population.
Results
Our approach and hypotheses incorporate three crucial
strategies: (i) sensitive, quantitative analysis of gene expression,
(ii) principal components analysis of cognitive test scores to better
reflect WS cognition, and (iii) correlation of cognitive performance
with WS gene expression within a cohort of WS cases with typical
deletions.
Gene Expression
Gene expression was analyzed using quantitative RT-PCR, as
described previously [14]. Briefly, subjects’ lymphoblastoid cell lines
were grown under controlled conditions. To assess WS-region gene
transcript levels, we isolated mRNA and performed quantitative
RT-PCRonFZD9,BAZ1B,STX1A,CLDN3,CLDN4,RFC2,CLIP2,
GTF2IRD1 (exon 2–3), GTF2IRD1 (exon 10–11), and GTF2I for
107 WS subjects (see map of deleted genes in WS in Fig. 1a). We
then calibrated the expression levels across subjects using the
comparative Ct method with ACTB, PPIA,a n dHPRT1 as reference
Figure 1. Distribution of quantitative transcription of genes deleted in WS. a: Map of genes commonly deleted in WS. Genes analyzed
in this report are indicated with an asterisk. b: Z-scores (relative to the WS mean) of STX1A expression levels. STX1A measured by quantitative
RT-PCR of lymphoblast cDNA in 62 WS subjects [14] (dark gray) and 45 normal controls [14] (light gray). The expression level distributions of the
remaining WS-deleted genes are shown in Figure S1.
doi:10.1371/journal.pone.0010292.g001
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WS gene expression were chosen in the previous study [14] because
two are on chromosome 7 (ACTB and PPIA), all three were
expressed in lymphocytes or lymphoblastoid cell lines, and their
expression levels were in the range of the WS genes measured in
normal controls. ACTB is highly and somewhat variably expressed.
HPRT1 is located on the X chromosome, which could potentially
generate additional variability, and was therefore not used for the
PC1 correlations. However, the DCt’s for each WS gene,
normalized with each of the three controls, follow a pattern similar
to that seen in [14]. No difference in the expression of control genes
was found in WS cases versus normal controls, although this is
another potential source of variation. The DCt’s for WS genes
normalized with ACTB are given in Supplemental Table 2 of
Collette, et al. [14], for both controls and WS cases. For the current
paper, we identified a sub-cohort of 65 subjects who had gene
expression and WAIS-R dataavailable.Of these65,probes failed in
3 subjects for STX1A normalized to both ACTB and PPIA, resulting
in 62 available subjects. This does not affect our results because the
gene expression experiment wasdone blindto their cognitivescores.
For this population, we calculated gene expression Z-scores, i.e., the
number of standard deviations by which an observation differs from
the population mean. The expression values used in this paper are
the average of the ACTB-controlled and PPIA-controlled Z-scores,
as shown for STX1A in Fig. 1b and for other genes in Fig. S1.
Quantitative PCR was used to confirm that deletions in all 65 WS
cases included STX1A, but all 10 normal controls included both
copies of STX1A (Fig. S2).
Measurement of WS Cognition I: WAIS-R
Williams Syndrome patients have mild intellectual deficiencies
but show a distinct pattern of weaknesses in subtests measuring
PIQ and relative strengths in VIQ. Figures 2a and 2b depict the
cognitive performance on the WAIS-R subtests and summary
measures for the WS patients in our cohort in comparison with
1880 normal controls [27]. For the WS cohort, the mean scores
were 67.368.4 for Full Scale IQ (FSIQ), 71.168.2 for Verbal IQ
(VIQ), and 65.868.3 for Performance IQ (PIQ), when compared
to the normal population. In the WS patients, PIQ is significantly
less than VIQ (one-tailed paired t-test, n=65, p=0.0001).
Relative to their overall performance, WS subjects tended to do
well in tests of vocabulary (Vocabulary) and abstract reasoning
(Similarities, Picture Arrangement), and poorly in tests of
numeracy (Arithmetic), visual-spatial (Digit Symbol, Block Design,
Object Assembly), and memory (Digit Span); these subtests are
described in Table S1. The distinct pattern of our cohort’s WAIS-
R subtest scores is similar to WS patients in other studies [28].
Measurement of WS Cognition II: Principal Components
Analysis
We next addressed the problem of how to better represent the
distinctive pattern of WS WAIS-R subtest scores. We could not
use the WAIS-R summary scores, Full Scale IQ (FSIQ), Verbal IQ
(VIQ), or Performance IQ (PIQ) for the measurement of WS
cognition because they are control-normalized averages of the
individual subtest scores and therefore may not be representative
of the subtest variability in WS. In the normal population, each
subtest is standardized to have a mean of ten and variance of
three, clearly different from the extensive variation of the subtests
in our WS patients (Fig. 2a). As explained earlier, PCA is capable
of capturing the common variability of the subtests with a reduced
number of components. The first generated component (PC1)
captures the maximum possible common variation. The subse-
quent components (PC2 through PC11) capture the sequentially
Figure 2. Cognitive performance in WS subjects (n=67) versus normal controls. a: Means (circles) and SD (bars) of WAIS-R subtest
scores for WS cases. Performance subtests are listed in bold; verbal subtests in plain font. In normal controls (NC), WAIS-R subtest scores are 1063
(thick gray line). b: Means (circles) and SD (bars) of VIQ, PIQ, and FSIQ scores for WS cases. In normal controls (NC), WAIS-R VIQ, PIQ, and
FSIQ scores are 100615 (thick gray line). c: Principal component analysis of WAIS-R shows subtests contribute differently to intelligence
in WS cases versus normal controls. WAIS-R subtest loadings on PC1 in WS cases (x-axis) and normal controls (y-axis). Data used for normal
analysis is from Enns and Reddon [27]. Performance subtests are listed in bold; verbal subtests in plain font. The iagonal line is x = y, at which WS and
normal loadings are equal.
doi:10.1371/journal.pone.0010292.g002
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accordingly extracted the principal components as summary
measures of intelligence for correlation against expression levels.
Our WS population of 65 subjects meets minimum require-
ments for principal components analysis of the correlation matrix
(Table S2) [29]. To objectively determine the number of
components within our dataset, we used three common methods:
(i) a Scree test [30], (ii) a Kaiser’s eigenvalue greater than one test
[31], and (iii) a parallel analysis using 10,000 column-wise
permutations of our dataset [32]. All three methods agree that
the first component (PC1) alone adequately summarizes IQ
variation in our WS sample accounting for 58% of the total
variance (Table S3). Figure 2c and Table S4 convey how each of
the various subtests loads on PC1 in WS cases versus on PC1
obtained in normal controls. For both WS cases and normal
controls, all subtests are significantly represented in PC1 (lowest
loading is 0.65 for WS cases, and 0.64 for normal controls).
However, for WS patients PC1 is more strongly influenced by the
five subtests: Block Design, Digit Symbol, Picture Arrangement,
Picture Completion and Vocabulary. Vocabulary is a subtest in
Verbal IQ; the other four are subtests in visual-spatial or
Performance IQ. A markedly different pattern is observed in
controls, where a larger influence on PC1 is from the five verbal
IQ subtests: Vocabulary, Information, Similarities, Comprehen-
sion, and Arithmetic. Thus, in general, scores on performance
subtests differentiate WS patients more cleanly than do verbal
subtests, whereas for controls, scores on verbal subtests differen-
tiate more cleanly. However, use of the appropriate PC1 would be
the best differentiator of any linear combination of subtests.
Correlation of gene expression with PC1
A previous paper [14] used a multiple regression model to
reveal that in a larger WS cohort gene levels were not related to
age, parent-of-origin of the deletion, or gender. For the current
paper, we identified a sub-cohort of 65 WS subjects with gene
expression data and WAIS-R subtest scores. We first correlated
the summary scores FSIQ, PIQ, and VIQ against gene expression
and obtained results which were not significant after Bonferroni
correction.
In order to relate gene expression to cognition, we utilized the
data reduction afforded by PCA and tested the correlation of the
ten expression levels against PC1 scores (Table 1). In this analysis,
PCA is blind to expression levels. Based on the standard one-tailed
large sample criterion, we found two significant correlations out of
ten tested Pearson correlations (STX1A with PC1, one-tailed
p=0.0007; FZD9 with PC1, one-tailed p=0.0076). Only the
correlation between PC1 and STX1A remains significant after
Bonferroni correction (corrected p=0.0073) (Table 1). To
determine whether PC1 might be related to STX1A through other
genetic mechanisms in this cohort of 65 WS, we tested the
correlation of STX1A to age, parent-of-origin of the deletion, and
gender. The detailed results are presented in a subsequent section,
however we found no significant relationship. Therefore, we
conclude that in our data STX1A expression is correlated with
intelligence as measured by PC1. Since large sample correlation
tests are potentially vulnerable to deviations from normality, we
also conducted a permutation test of the correlation between
STX1A and PC1 by permuting PC1 across subjects one million
times (SPSS 15.0) (Fig. 3b). Of the one million permutations, only
756 of the computed STX1A and PC1 correlations were more
extreme in the positive direction than the observed correlation
(Bonferroni corrected p=0.0076). This suggests our results are not
due to chance alone. Furthermore, the permutation tests
summarized in Figure 3b do not show any other significant
correlations between WS genes and PC1 after correction,
suggesting a unique role for STX1A among the ten tested genes.
Finally, we determined that STX1A explains 15.6% of PC1
variability in WS patients by regressing PC1 scores out of STX1A
expression and calculating the percentage reduction in variance
(initial variance =0.878, final variance =0.741). To our
knowledge, this is the highest correlation reported between
expression of a single gene and intelligence within a human
population [2,3].
Correlation of gene expression with WAIS-R subtests
The data indicate a correlation between STX1A levels and WS
intelligence as expressed by PC1, but we sought to determine
whether there was a direct correlation with intelligence subtests.
To investigate this question, we computed the correlation of each
of the ten expression levels against each of the eleven WAIS-R
subtests (Table S6). We found 25 significant correlations (one-
tailed Pearson correlation, significance threshold p=0.05) out of
110 tested. Of these, only the correlation between STX1A levels
and Digit Symbol scores remained significant after Bonferroni
correction (corrected p-value=0.035). Digit Symbol is a multifac-
eted test measuring multiple skills, including visual memory,
spatial memory, motor speed, perceptual processing speed, visual
scanning efficiency, and executive function [33]. This makes Digit
Symbol a good candidate for a more global measure of
intelligence.
Table 1. Correlation between quantitative expression of WS genes and intelligence measured by Principal Component 1 (PC1) of
the WAIS-R subtests.
FZD9 BAZ1B STX1A CLDN3 CLDN4 RFC2 CLIP2 GTF2IRD1 (2-3) GTF2IRD1 (10-11) GTF2I
n 65 65 62 65 65 65 65 65 65 65
r 0.299 -0.030 0.396 0.166 0.126 -0.125 0.021 0.158 0.156 -0.078
Asymptotic p-value 0.008 0.405 0.0007 0.093 0.158 0.162 0.435 0.105 0.107 0.267
Corrected
asymptotic p-value
0.077 — 0.0073 0.925 — — — — — —
Permuted p-value 0.008 0.405 0.0008 0.092 0.158 0.162 0.436 0.105 0.108 0.268
For each gene, the values listed from top to bottom are: the number of WS subjects with expression levels available (n); the Pearson correlation coefficient (r); the one-
tailed asymptotic p-value generated under the assumption of normality (uncorrected for multiple tests); the Bonferroni corrected p-value (or a — if Bonferroni
correction results in a value greater than 1.0); and the permutation p-value as shown in Figure 3b (10
6 permutations; uncorrected for multiple tests). This is shown for
STX1A in Figure 3a.
doi:10.1371/journal.pone.0010292.t001
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of the deletion, or gender
As mentioned above, to determine whether PC1 might be related
to STX1A through other established genetic mechanisms, we tested
the correlation of STX1A to age, parent-of-origin of the chromo-
some deletion, and gender; we found no significant relationships.
PC1 is not related to: subject age (two-tailed Pearson correlation,
n=65, p=0.4286); subject age at cell line creation (two-tailed
Pearson correlation, n=65, p=0.3683); subject age at WAIS-R
administration (two-tailed Pearson correlation, n=65, p=0.3715);
age of cell line (two-tailed Pearson correlation, n=65, p=0.6735);
parent-of-origin of the deletion (two-tailed t-test, n=55,
p=0.5005); or gender (two-tailed t-test, n=65, p=0.8187). STX1A
expression level is not related to: subject age (two-tailed Pearson
correlation, n=62, p=0.1063); subject age at cell line creation
(two-tailed Pearson correlation, n=62, p=0.1032); subject age at
WAIS-R (two-tailed Pearson correlation, n=62, p=0.1049); age of
cell line (two-tailed Pearson correlation, n=62, p=0.9404); parent-
of-origin of the deletion (two-tailed t-test, n=53, p=0.5653); or
gender (two-tailed t-test, n=62, p=0.9584). Due to a possible weak
relationship between subject age and STX1A expression, we
performed a partial correlation between STX1A and PC1 after
removing variance added by subject age. The relationship between
STX1A and PC1 remains highly significant (one-tailed Pearson
correlation, n=62, p=0.0003).
Discussion
Nobel Laureate Barbara McClintock once admonished me
(JRK), ‘‘Let the data speak to you.’’ Therefore, although
unexpected and of unknown mechanism, our data indicate that
peripheral STX1A expression levels measured in lymphoblastoid
cell lines strictly grown, is related to an emergent property of the
CNS, intelligence. The cellular and synaptic neurobiology of
STX1A is best known as an important component of the
presynaptic SNARE complex involved in priming of synaptic
vesicles for release. This points to the dosage sensitive modulation
of the synapse as one possible aspect of intelligence and to
lymphoblastoid cell lines as a possible cellular assay system.
Specifically, our results indicate that STX1A is expressed in
lymphoblastoid cells, where its transcript level is affected by WS
gene deletion and correlated with WS cognition. After Bonferroni
correction, the correlation is more significant for PC1 than for
PIQ, VIQ, and FSIQ (Table S5), or any single subtest (Table S6).
This is not surprising, given that PC1 explains far more of the
variation in the WS patients than does any subtest. Taken
together, our results are a first step towards dissecting the
molecular basis of cognition in WS.
Three other lines of evidence support a role for STX1A in
learning and memory in WS. First, STX1A is largely expressed in
the brain regions involved in learning, memory, and fear (cerebral
cortex, hippocampus, and amygdala, respectively; http://www.
brain-map.org). STX1A is an important component of the
synapse, where it localizes at the presynaptic membrane and
functions as a part of the Q-SNARE (glutamine soluble N-
ethylmaleimide sensitive attachment receptor) complex to regulate
neurotransmission through calcium-mediated exocytosis of synap-
tic vesicles [34,35]. Moreover, STX1A also interacts with and co-
regulates multiple ion channel types and neurotransmitter
transporters (e.g., sodium ENaC, potassium KCNB1, and
dopamine DAT; Table S7). The second line of evidence is that
the Stx1a knockout mouse shows impaired hippocampal long-term
potentiation and impaired fear memory consolidation and
extinction, despite normal brain structure and morphology [36].
Expression of the STX1A isoform, STX1B, is not elevated in the
knockout, suggesting independent function despite co-localization
in many but not all brain regions [37]. The third line of evidence is
that syntaxin 1A protein levels are increased in autism [38] and
decreased in prefrontal cortical neurons in persons with advanced
Alzheimer disease (ELISA, t-test p=0.0003) [39], along with other
presynaptic proteins. Combined with our results, these biological
clues support a role for STX1A in the deficits of learning and
memory in WS.
How might STX1A expression in lymphoblastoid cell lines be
related to neural function? It seems rather extraordinary that our
approach indicates STX1A expression in LB lines might explain as
much as 15.6% of the variance in the first principal component of
general intelligence in WS measured by the WAIS-R. As with all
Figure 3. STX1A quantitative expression is correlated with intelligence in WS measured by Principal Component 1 of the WAIS-R
subtests. a: Correlation between STX1A expression and PC1. The Y-axis is Z-scores of STX1A expression and the X-axis is PC1 (Pearson
correlation p=0.0007, Bonferroni corrected p=0.0073). b: T-ratio distribution of 10
6 permuted correlations between PC1 and STX1A
expression. In our cohort of 65 WS cases, the t-ratio for PC1 versus the WS genes demonstrates that only the correlation with STX1A is not explained
by chance alone (Pearson correlation p=0.0008, Bonferroni corrected p=0.008).
doi:10.1371/journal.pone.0010292.g003
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combining cognitive with cellular and genetic analyses. However,
one possible explanation is that STX1A expression in brain may be
the same as that in lymphoid tissue or in lymphoblastoid cells
grown under the same conditions, even though it may have no
functional consequences in LB lines. Another possibility is that
STX1A expression in brain may vary with intelligence and perform
a cellular role related to that in lymphoblastoid cells. One role
STX1A may have in common is SNARE mediating calcium
stimulated vesicle fusion both at the neural synapse and at the
plasma membrane in non-excitable tissues [40]. Although the role
of STX1A in the immune system is less clear, it is involved in
exocytosis in some non-excitable tissues, such as insulin secretion
by beta cells of the exocrine pancreas and antibody secretion
(http://www.genecards.org/index.shtml) [41]. Alternatively, the
connection between the peripheral and central role of STX1A
may be mediated by immune-nervous system interactions
involving both CD4+ and CD8+ lymphocytes that express STX1A
and enter the central nervous system [42]. Other mechanisms may
involve cytokines, known regulators of brain activity, or other
similarities of the immune and nervous synapses [43]. It will be of
interest to elucidate the possible role of STX1A in immune
regulation as this may provide insight into cellular pathways in
common with the brain [40].
WS is an informative model for dissecting the genetic
contributions to human intelligence. Studies of individuals with
smaller deletions have already implicated the genes GTF2IRD1
and GTF2I as involved in the characteristic WS deficits in visual-
spatial construction [7,8,9,10]. Cognitive deficits remain, however,
when these genes are not deleted. It is important to note that a
given gene may affect intelligence through multiple causal routes
during brain development, post-natal brain function at the
synapse, or metabolically. To pinpoint the contributions of other
genes to WS cognition we need further genetic sequence or
methylation information to identify different subgroups, and to
determine if cognition varies among the groups. For example,
position effects on genes flanking the deletion may also affect WS.
Other genetic mechanisms that may affect WS phenotypes include
DNA sequence variations and epigenetic effects originating either
from WS genes expressed on the non-deleted chromosome 7 or
from the remainder of the genome. Association studies in the
normal population designed to detect these effects are limited by
the large sample sizes required to overcome the pitfalls of multiple
testing. Further limitations of these studies are the large number of
genes that undoubtedly influence intelligence and that the effects
of any one gene are apt to be small. Finally, if expression levels
rather than allele differences are used as predictors of cognitive
processes, then inevitable questions for study replication arise
concerning the lack of sensitivity and specificity of various array
gene expression chips compared to RT-PCR. In contrast, in WS,
we have analyzed a large cohort of individuals with sensitive
genetic tests to show that variation in a single gene can explain
15.6% of the first principal component of intelligence. Further
analyses of DNA sequence and gene expression in this cohort may
reveal other genes encoding proteins involved in neuronal synaptic
transmission as contributing to intelligence and behavior. Some of
these genes may well turn out to be predictive of cognitive
function, either in the entire population or perhaps only in those
with lower IQ’s. Alternatively, STX1A may be related to
intelligence only in WS. These questions are an important
direction for future study.
The most profitable place to start preliminary investigation of
intelligence in the normal population may be with STX1A itself. For
example, simple linear extrapolation of the relationship between IQ
and STX1A in WS predicts normal IQ from normal STX1A
expression (Fig. 4). In particular, the STX1A expression in our 45
normal controls predicts a mean IQ of 91.1 (ACTB normalized
expression) to 105.0 (PPIA normalized expression). In future studies,
it will be important to further test this correlation in the normal
population, using either STX1A gene variation or expression.
To our knowledge, this is one of the first links between a cellular
process and an emergent property of neural circuits. Further
progress in dissecting the genetics and neurobiology of human
cognition will require similar integrative research. The study of
WS opens a unique window into this complex world. With good
luck and hard work, similar analyses of neurodevelopmental
disorders may reveal more of Nature’s hand in shaping intelligence
at the synapse.
Figure 4. Linear extrapolation between IQ and STX1A levels in
WS predicts normal IQ from expression in normal controls. Low
IQ WS is defined as cases at or below the median FSIQ for the WS
subjects; High IQ WS is at or above the median. The Low IQ WS group
(n=31) had IQ scores 60.1365.30; the High IQ WS group (n=31) had IQ
scores 74.2964.09. The middle line across each diamond is the group
mean Z-score for STX1A expression. The vertical span of each diamond
represents the 95% confidence interval for each group. The mean 6
standard deviation of STX1A expression for Low IQ WS is 20.3660.85;
for High IQ WS it is 0.3560.90; and for normal controls it is 1.5260.90. P-
values are derived from a two-tailed Student’s t-test. Simple linear
extrapolation then implies that the STX1A expression levels in the
normal controls (n=45) predict a mean IQ from 91.1 (ACTB normalized
expression) to 105.0 (PPIA normalized expression). These data suggest
that STX1A expression may be related to variability in IQ in WS and in
the normal population. This conclusion merits further study but could
provide a peripheral assay system that reflects vesicle fusion
functioning at the synapse. It will be of interest to examine, with
sensitive QRT-PCR methods, other genes encoding synaptic proteins, as
these become similar candidates for neurocellular processes.
doi:10.1371/journal.pone.0010292.g004
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Patient Population, Ethics Statement, and Data Analysis
Our population of 65 WS patients includes 34 females and 31
males with average age at cell line creation of 28.769.0 years. This
study was conducted in accordance with the principles expressed in
the Declaration of Helsinki. The subjects and their families were
recruited as part of an ongoing research study approved by the
Institutional Review Boards at Cedars-Sinai Medical Center
(CSMC) or The Salk Institute. All patients provided written
informed consent for the collection of samples and subsequent
analysis. In each case the diagnosis of WS was determined by
medical history, clinical studies, and laboratory analysis using FISH
(fluorescenceinsituhybridization).MulticolorFISHthenconfirmed
diagnosis using a panel of well-characterized BACs from both the
deleted and flanking duplicated regions as previously described in
detail [8]. In typical WS, where single copy BACs for the elastin
locus (592D8) or those flanking STX1A are deleted (including
1008H17 and 315H11 centromeric, and 1184P14 telomeric), the
region containing STX1A is included in the deletion, as are regions
identifiedbyBACs fortheduplicated regions (including239C10).In
order to validate the deletion of STX1A in WS subjects, quantitative
PCR using TaqMan assay primer sets (Applied Biosystems, USA)
on the DNA extracted from the lymphoblastoid cells lines were
performed on 65 WS subjects and 10 normal parental controls.
Standardized TaqMan RNase P Control (VIC) reagents were used
as the endogenous reference (2 copies) in multiplex reactions. A
custom TaqMan assay for STX1A was designed with the forward
primer as 59-ACCCTCAAAACGGTTCATTCGT-39, the reverse
primer as 59-CCAGGTTCAGTGCTCTTTCACA-39, and the
FAM reporter sequence as 59-CTGGCTCAGCAGCTCC-39. All
WS subjects completed the WAIS-R test [5] and donated cells for
quantitative gene expression analysis. The WAIS-R testing was
conducted largely at the same time as the blooddraw forLB cell line
generation (on the same day for 42 subjects, within 2 years for an
additional 18 subjects, and within 4–8 years for the remaining 5
subjects, all of whom were 21–46 years old). All cell lines were
generated at CSMC using standard methods.
All correlations performed are Pearson’s correlations. We used
SPSS 15.0 (www.spss.com) to perform principal components
analysis and permutation analysis. All other statistical analyses
were performed using JMP 7 (www.jmp.com).
Supporting Information
Figure S1 Gene expression level measured by quantitative RT-
PCR [14] in WS subjects and normal controls. Expression levels
measured by quantitative RT-PCR of lymphoblast cDNA of genes
FZD9 (n=65 WS subjects), BAZ1B (65), STX1A (62), CLDN3
(65), CLDN4 (65), RFC2 (65), CLIP2 (65), GTF2IRD1 (exon 2-3)
(65), GTF2IRD1 (exon 10-11) (65), and GTF2I (65) in WS subjects
(dark grey) and normal controls (light grey) are graphed as z-scores
relative to the WS mean.
Found at: doi:10.1371/journal.pone.0010292.s001 (16.88 MB
TIF)
Figure S2 The deletion of STX1A was confirmed by quantita-
tive PCR in 65 WS subjects and 10 normal controls. A custom
TaqMan assay for STX1A was used with standardized TaqMan
RNase P Control (VIC) reagents as the endogenous reference. The
mean relative copy number of STX1A is 1.0560.15 in WS
(n=65, solid diamonds) and 1.9660.14 in normal controls (n=10,
solid dots).
Found at: doi:10.1371/journal.pone.0010292.s002 (3.99 MB TIF)
Table S1 WAIS-R subtest descriptions [5, S2].
Found at: doi:10.1371/journal.pone.0010292.s003 (0.04 MB
DOC)
Table S2 WAIS-R subtest correlation matrix (R2 values) in WS
cases (n=65) and in normal controls. Lower triangle (italics)
represents correlations in WS cases; upper triangle represents
correlations in normal controls [5]. Performance subtests are listed
in bold; verbal subtests in plain font.
Found at: doi:10.1371/journal.pone.0010292.s004 (0.05 MB
DOC)
Table S3 Proportion of variance in WAIS-R subtests explained
by PCA Components 1-11 in our WS cohort. Component 1 alone
explains 57.6% of the variance in WAIS-R subtests.
Found at: doi:10.1371/journal.pone.0010292.s005 (0.04 MB
DOC)
Table S4 WAIS-R subtest loadings on the first principal
component in WS cases and in normal controls. Performance
subtests are listed in bold; verbal subtests in plain font. Loadings
for normal controls are derived from Enns and Reddon [27].
Found at: doi:10.1371/journal.pone.0010292.s006 (0.03 MB
DOC)
Table S5 Correlation between quantitative expression of WS
genes and WAIS-R VIQ, PIQ, and FSIQ in WS cases. For each
gene and test, the top number is the Pearson correlation coefficient
(r) and the bottom number is the one-tailed p-value (uncorrected
for multiple tests).
Found at: doi:10.1371/journal.pone.0010292.s007 (0.05 MB
DOC)
Table S6 Correlation between quantitative expression of WS
genes and WAIS-R subtest scores in WS cases. For each gene and
test, the top number is the Pearson correlation coefficient (r) and
the bottom number is the one-tailed p-value (uncorrected for
multiple tests).
Found at: doi:10.1371/journal.pone.0010292.s008 (0.09 MB
DOC)
Table S7 Syntaxin 1A binds to and regulates multiple ion
channels and neurotransmitter transporters. STX1A performs this
function in addition to its role in presynaptic vesicle processing.
Found at: doi:10.1371/journal.pone.0010292.s009 (0.04 MB
DOC)
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